o Accelagen is a full-service Australian Bio-pharmaceutical and Medical Device Development Organisation. We provide high quality regulatory affairs and clinical research services globally, with a level of professionalism and dedication that always exceeds our clients’ expectations.
o Based in Melbourne, our expert team works with clients around the world. Using in-depth knowledge of therapeutic areas and experience with design/execution of clinical trials, together with a dedicated service to the evolution of new technologies, we strive to make a difference in everything we do.
o Accelagen can also support organisations with strategic alliances to expert partners through all stages of a products lifecycle.
o Importantly, our team operates with a strong commitment to bring to life our company values each day – ultimately aiming to be the clinical research and regulatory affairs partner of choice.
o Based in Melbourne, our expert team works with clients around the world. Using in-depth knowledge of therapeutic areas and experience with design/execution of clinical trials, together with a dedicated service to the evolution of new technologies, we strive to make a difference in everything we do.
o Accelagen can also support organisations with strategic alliances to expert partners through all stages of a products lifecycle.
o Importantly, our team operates with a strong commitment to bring to life our company values each day – ultimately aiming to be the clinical research and regulatory affairs partner of choice.
Location: Australia, Victoria, Melbourne
Employees: 11-50
Founded date: 2010
Mentions in press and media 2
| Date | Title | Description |
| 03.04.2025 | Revolutionizing Spinal Cord Injury Treatment: Insights from a World-First Clinical Trial Conducted in Melbourne, Australia, Upcoming Webinar Hosted by Xtalks | https://accelagen.com.au/ In this free webinar, learn about the years of discovery research leading to a world-first clinical trial for spinal cord injury treatment. Attendees will gain insight into the unique challenges and strategies invo... |
| 20.09.2022 | Rapid growth puts Australian CRO Accelagen on the map for clinical research globally | With over 110% revenue growth in the last two years, Accelagen announces move to new office space in Hawthorn East, Melbourne MELBOURNE, Australia, Sept. 20, 2022 /PRNewswire/ -- Accelagen, one of Australia's leading Contract Research Organ... |